Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioCryst Pharmaceuticals Inc. June 11, 202696.2%
-
BioCryst Pharmaceuticals Inc. June 13, 202388.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| Mar 20, 2026 | BioCryst Pharmaceuticals Inc. | Option exercise | +49,933 | $6.30 | $314,578 |
| Mar 20, 2026 | BioCryst Pharmaceuticals Inc. | Open-market sale | −49,933 | $10.11 | $504,823 |
| Aug 13, 2025 | BioCryst Pharmaceuticals Inc. | Option exercise | +30,000 | $2.91 | $87,300 |
| Aug 13, 2025 | BioCryst Pharmaceuticals Inc. | Option exercise | +40,000 | $5.41 | $216,400 |
| Aug 13, 2025 | BioCryst Pharmaceuticals Inc. | Open-market sale | −70,000 | $8.51 | $595,700 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Jun 14, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −6,698 | $6.11 | $40,925 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| May 31, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +870 | $6.46 | $5,620 |
| Feb 29, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +999 | $5.63 | $5,624 |
| Nov 30, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +956 | $5.88 | $5,621 |
| Aug 31, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +791 | $7.11 | $5,624 |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
| May 31, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +680 | $8.27 | $5,624 |
Questions about Theresa Heggie
What boards is Theresa Heggie on?
Theresa Heggie sits on the boards of BioCryst Pharmaceuticals Inc. and ProQR Therapeutics N.V.
How long has Theresa Heggie served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.